The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice

Jakobsson, 2012, Liver X receptor biology and pharmacology: new pathways, challenges and opportunities, Trends Pharmacol. Sci., 33, 394, 10.1016/j.tips.2012.03.013 Steffensen, 2013, Targeting liver X receptors in inflammation, Expert opin. Therapeut. Targets, 17, 977, 10.1517/14728222.2013.806490 Joseph, 2003, Reciprocal regulation of inflammation and lipid metabolism by liver X receptors, Nat. Med., 9, 213, 10.1038/nm820 Ghisletti, 2007, Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma, Mol. Cell, 25, 57, 10.1016/j.molcel.2006.11.022 Hindinger, 2006, Liver X receptor activation decreases the severity of experimental autoimmune encephalomyelitis, J. Neurosci. Res., 84, 1225, 10.1002/jnr.21038 Xu, 2009, Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity, J. Leukoc. Biol., 86, 401, 10.1189/jlb.1008600 Cui, 2011, Liver X receptor (LXR) mediates negative regulation of mouse and human Th17 differentiation, Journal of Clinical Investigation, 121, 658, 10.1172/JCI42974 Wang, 2009, Liver X receptor agonist GW3965 dose-dependently regulates LPSmediated liver injury and modulates post-transcriptional TNFalpha production and p38 MAPK activation in liver macrophages, Shock, 32, 548, 10.1097/SHK.0b013e3181a47f85 Kiss, 2011, Suppression of chronic damage in renal allografts by Liver X receptor (LXR) activation relevant contribution of macrophage LXRalpha, Am. J. Pathol., 179, 92, 10.1016/j.ajpath.2011.03.019 Kiss, 2013, Lipid droplet accumulation is associated with an increase in hyperglycemia-induced renal damage: prevention by Liver X Receptors, Am. J Pathol., 182, 727, 10.1016/j.ajpath.2012.11.033 Loftus, 2004, Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences, Gastroenterology, 126, 1504, 10.1053/j.gastro.2004.01.063 Molodecky, 2012, Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review, Gastroenterology, 142, 46, 10.1053/j.gastro.2011.10.001 Xavier, 2007, Unravelling the pathogenesis of inflammatory bowel disease, Nature, 448, 427, 10.1038/nature06005 Strober, 2007, The fundamental basis of inflammatory bowel disease, J. Clin. Invest., 117, 514, 10.1172/JCI30587 Atreya, 2010, Chemokines in inflammatory bowel diseases, Dig. Dis., 28, 386, 10.1159/000320392 Lazennec, 2010, Chemokines and chemokine receptors: new insights into cancer-related inflammation, Trends Mol. Med., 16, 133, 10.1016/j.molmed.2010.01.003 Lee, 2008, Differential regulation of chemokines by IL-17 in colonic epithelial cells, J. Immunol., 181, 6536, 10.4049/jimmunol.181.9.6536 MacDonald, 2010, Inside the microbial and immune labyrinth: Totally gutted, Nature Medicine, 16, 1194, 10.1038/nm1110-1194 Wirtz, 2007, Chemically induced mouse models of intestinal inflammation, Nat. Protoc., 2, 541, 10.1038/nprot.2007.41 Mariathasan, 2004, Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf, Nature, 430, 213, 10.1038/nature02664 Hu, 2012, LXRbeta activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile, J Intern. Med., 272, 452, 10.1111/j.1365-2796.2012.02529.x Rovedatti, 2009, Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease, Gut, 58, 1629, 10.1136/gut.2009.182170 Awane, 1999, NF-kappa B-inducing kinase is a common mediator of IL-17-, TNF-alpha-, and IL-1 beta-induced chemokine promoter activation in intestinal epithelial cells, J. Immunol., 162, 5337, 10.4049/jimmunol.162.9.5337 Mahida, 1992, Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis, Clin. Sci., 82, 273, 10.1042/cs0820273 Izzo, 1993, Neutrophil-activating peptide (interleukin-8) in colonic mucosa from patients with Crohn's disease, Scand. J. Gastroenterol., 28, 296, 10.3109/00365529309090244 Raab, 1993, Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis, Gut, 34, 1203, 10.1136/gut.34.9.1203 Banks, 2003, Chemokine expression in IBD. Mucosal chemokine expression is unselectively increased in both ulcerative colitis and Crohn's disease, J. Pathol., 199, 28, 10.1002/path.1245 Uguccioni, 1999, Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis, Am. J. Pathol., 155, 331, 10.1016/S0002-9440(10)65128-0 Mazzucchelli, 1996, Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease, J. Pathol., 178, 201, 10.1002/(SICI)1096-9896(199602)178:2<201::AID-PATH440>3.0.CO;2-4 Reinecker, 1995, Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa, Gastroenterology, 108, 40, 10.1016/0016-5085(95)90006-3 Egesten, 2007, The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids, Int. J. Colorectal Dis., 22, 1421, 10.1007/s00384-007-0370-3 Sasaki, 2002, Blockade of CXCL10 protects mice from acute colitis and enhances crypt cell survival, Eur. J. Immunol., 32, 3197, 10.1002/1521-4141(200211)32:11<3197::AID-IMMU3197>3.0.CO;2-1 Andres, 2000, Mice with a selective deletion of the CC chemokine receptors 5 or 2 are protected from dextran sodium sulfate-mediated colitis: lack of CC chemokine receptor 5 expression results in a NK1.1+ lymphocyte-associated Th2-type immune response in the intestine, J. Immunol., 164, 6303, 10.4049/jimmunol.164.12.6303 Venteclef, 2010, GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXR  in the hepatic acute phase response, Genes & Development, 24, 381, 10.1101/gad.545110 Bensinger, 2008, LXR signaling couples sterol metabolism to proliferation in the acquired immune response, Cell, 134, 97, 10.1016/j.cell.2008.04.052 Huang, W. et al. Coronin 2A mediates actin-dependent de-repression of inflammatory response genes. Nature470, 414–418. Joseph, 2004, LXR-dependent gene expression is important for macrophage survival and the innate immune response, Cell, 119, 299, 10.1016/j.cell.2004.09.032 Geyeregger, 2007, Liver X receptors regulate dendritic cell phenotype and function through blocked induction of the actin-bundling protein fascin, Blood, 109, 4288, 10.1182/blood-2006-08-043422 Torocsik, 2010, Activation of Liver X Receptor Sensitizes Human Dendritic Cells to Inflammatory Stimuli, The Journal of Immunology, 184, 5456, 10.4049/jimmunol.0902399 Lee, 2009, Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes, Mol. Cell, 35, 806, 10.1016/j.molcel.2009.07.021 Abraham, 2009, Inflammatory bowel disease, N. Engl J. Med., 361, 2066, 10.1056/NEJMra0804647 Andersen, 2011, Polymorphisms in NF-kappaB, PXR, LXR, PPARgamma and risk of inflammatory bowel disease, World J. Gastroenterol., 17, 197, 10.3748/wjg.v17.i2.197 Yasuda, 2010, Tissue-specific liver X receptor activation promotes macrophage reverse cholesterol transport in vivo, Arterioscler. Thromb. Vasc. Biol., 30, 781, 10.1161/ATVBAHA.109.195693 Plat, 2005, Plant sterols and stanols: effects on mixed micellar composition and LXR (target gene) activation, J. Lipid Res., 46, 2468, 10.1194/jlr.M500272-JLR200 Viennois, 2011, Selective liver X receptor modulators (SLiMs): What use in human health?, Mol. Cell. Endocrinol., 351, 129, 10.1016/j.mce.2011.08.036 Jakobsson, 2009, GPS2 is required for cholesterol efflux by triggering histone demethylation, LXR recruitment, and coregulator assembly at the ABCG1 locus, Mol. Cell, 34, 510, 10.1016/j.molcel.2009.05.006 Alberti, 2001, Hepatic cholesterol metabolism and resistance to dietary cholesterol in LXRbeta-deficient mice, J. Clin. Invest., 107, 565, 10.1172/JCI9794 Gabbi, 2012, Central diabetes insipidus associated with impaired renal aquaporin-1 expression in mice lacking liver X receptor beta, Proc. Natl Acad. Sci. USA, 109, 3030, 10.1073/pnas.1200588109 Weigmann, 2007, Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue, Nat. Protoc., 2, 2307, 10.1038/nprot.2007.315